GlassScriptPhysician profile
Ahmed Kazem
NPI 1003376963
$3,298.86
in general payments reported to CMS, 2019-2025
12 companies · $819 in 2025
The $819 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $303 · 2023: $1,063 · 2024: $1,113 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,603 · Education: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,602.59 |
| Education | $393.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $748.13 | 2023-2025 | Resolute Onyx, Turbohawk, Onyx Frontier |
| Abiomed | $530.88 | 2023-2025 | Impella |
| Boston Scientific Corporation | $393.44 | 2023-2024 | Mamba |
| Philips North America LLC | $355.07 | 2023-2024 | (P88) Igt Devices Fm, (9520) Igt Devices Undivided |
| Inari Medical, INC. | $324.18 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $213.66 | 2022-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Angiodynamics, INC. | $192.95 | 2022-2025 | Alphavac |
| Shockwave Medical, INC | $173.56 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $172.08 | 2024 | |
| Penumbra, INC. | $163.96 | 2025 | Penumbra System |
| Merck Sharp & Dohme LLC | $16.49 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.46 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Kazem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.